Molecular therapies for cancer represent a revolutionary advance in the fight against this complex group of diseases.In recent research from Harvard's Chemistry and Chemical Biology Department, scientists have made significant strides in understanding how specific gene mutations can drive oncogenic processes, and how molecular glues can be utilized to disrupt the protein interaction networks that fuel cancer growth.